2-Chloro-5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

Catalog No. :
ACZIXV863
CAS No. :
1244039-65-3
Molecular Formula :
C12H16BClFNO2
Molecular Weight :
271.53

IUPAC Name:2-Chloro-5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline

2-Chloro-5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$552.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
IUPAC Name2-Chloro-5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
MDL No.MFCD22207090
Molecular FormulaC12H16BClFNO2
Molecular Weight271.53
SMILESNC1=CC(F)=CC(B2OC(C)(C)C(C)(C)O2)=C1Cl
InChI KeyLXMXPKGROLGLJT-UHFFFAOYSA-N
Synonym2-chloro-5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline;(3-AMINO-2-CHLORO-5-FLUOROPHENYL)BORONIC ACID PINACOL ESTER;Benzenamine, 2-chloro-5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
CAS No.1244039-65-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACZIXV863 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACGXHJ802 route compound structure diagram
    ACGXHJ802187929-81-3 In Stock
  4. Then
  5. ACZIXV863 route product structure diagram
    ACZIXV8631244039-65-3
Inquiry

2. ACZIXV863 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZIXV863 route product structure diagram
    ACZIXV8631244039-65-3
Inquiry

Comments (0)